Positive results from hVIVO study of Cidara flu candidate
Study demonstrated a reduction in viral replication in the upper respiratory tract as well as influenza infection
Read More
Tag: Cidara
Cidara, Mundipharma team up to commercialise Rezafungin
The total transaction value could exceed $568 million.
Read More
- Pierre Fabre Laboratories secures CHMP backing for first‑line BRAFTOVI regimen
- Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis
- KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy
- Pepaxti study supports use in wider myeloma population
- UCB reports positive outcomes for bimekizumab in psoriatic arthritis
